Create your beautiful and unique blog. It's Free.

Latest Blogs




Anti-Obesity Prescription Drugs Market Interpreted by a New Report

The global anti-obesity prescription drugs market is expected to see promising growth in forthcoming year, as reported by Transparency Market Research (TMR). Because of the lower rate of achievement and removal of centralized drugs, several of the leading firms have regarded the manufacture of anti-obesity drugs as being prohibitively dangerous and have changed their drive to the extension of the diabetic range into obesity. As a powerful connection between type 2 diabetes and obesity has been established by various businesses, it is often regarded a low-risk strategy and a minor R&D investment in prospective medications for anti-obesity. While the major players in the market have created a powerful footing for progressive market development, tiny and medium-sized players are far from building their market bases. The fresh and emerging market suppliers are anticipated, in order to improve growth opportunities, to follow the footsteps of established companies. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34835 In the

Details

Anti-Obesity Prescription Drugs Market Interpreted by a New Report

The global anti-obesity prescription drugs market is expected to see promising growth in forthcoming year, as reported by Transparency Market Research (TMR). Because of the lower rate of achievement and removal of centralized drugs, several of the leading firms have regarded the manufacture of anti-obesity drugs as being prohibitively dangerous and have changed their drive to the extension of the diabetic range into obesity. As a powerful connection between type 2 diabetes and obesity has been established by various businesses, it is often regarded a low-risk strategy and a minor R&D investment in prospective medications for anti-obesity. While the major players in the market have created a powerful footing for progressive market development, tiny and medium-sized players are far from building their market bases. The fresh and emerging market suppliers are anticipated, in order to improve growth opportunities, to follow the footsteps of established companies. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34835 In the

Details

Carglumic Acid Market Industry Players Are Leveraging Market Growth According to Demand Forecasts

The demand within the global market for carglumic acid has been rising on account of advancements in the pharmaceutical industry, finds Transparency Market Research (TMR). Carglumic acid is used to manufacture several forms of therapeutic tablets, and this is a key standpoint from the perspective of market growth. The leading vendors in the global carglumic acid market have set on a spree to tie up with new selling points for this acid. This strategy will not just earn a greater market share for the players, but shall also bring in humongous revenues into their kitty. The global carglumic acid market is expected to undergo successive fragmentation as several smaller vendors come under the spotlight of attention. Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35954 There is a high possibility of healthcare entities investing in the global carglumic acid market in the years to come. This trend shall pave way for the inflow of increased revenues into business of small and large vendors in the global carglumic acid market. The medium-sized

Details

Influenza Medication Market Investigated in the Latest Research

The global market for influenza medication is displaying a highly competitive business structure, finds a new research study by Transparency Market Research (TMR). Daiichi Sankyo Co., GlaxoSmithKline plc, Natco Pharma, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd. and Mylan Inc. are some of the prominent players operating in this market. Read Report Overview - https://www.transparencymarketresearch.com/influenza-medication-market.html However, only a few players have acquired the leading position, making the business landscape in this market moderately consolidated. The leading vendors of influenza medication are expected to take up strategic partnerships, states the market study. According to the research report, the global influenza medication market was worth US$1.69 bn in 2016. Expanding at a CAGR of 1.40% during the period from 2017 to 2025, the market is projected to reach US$2.01 bn by the end of the forecast period. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24038 zanamivir,

Details

Equine Healthcare Market Estimated to Grow According to Forecasts

Presence of large numbers of players engaged in manufacturing of equine healthcare products renders the global market increasingly fragmented. The players span across geographies, and are targeting geographic expansion as a part of the key strategies in the equine healthcare market. A number of regional markets have gathered momentum over the past few years. Asia Pacific has been offering new streams of revenues to key players in the equine healthcare market. Well-entrenched players in the global equine healthcare market are Equine Products (UK) Ltd., Ceva Santé Animale, Vetoquinol S.A., Sanofi, and Eli Lilly and Company. The equine industry has made considerable advances, riding on the back of large numbers of equine events across the globe. This has propelled the need for high quality breed horses. Revival of horse racing competitions especially in China has opened new revenue streams for manufacturers of equine healthcare products. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1603 Clocking a CAGR of 4.2%, the

Details

Neuroprotection Market Edited by Leading Research Firm

The global neuroprotection market was valued at approximately US$ 47,000.0 Mn in 2016 is projected to register a  growth rate of  8.2% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that increasing incidence and prevalence rates of neurological disorders such as Alzheimer’s, Parkinson’s, Macular Sclerosis ,and other neurological conditions causing neural damage is expected to assist the growth of neuroprotection market in the coming years (2017 to 2025). As major drug manufacturers are growing their product portfolios by increasing product development in developed markets such a North America and Europe region along with increasing strategic collaboration with regional players in developing economies. The North America, Europe, and Asia Pacific regions are likely to account for major share in the global neurprotection market. Increasing drug trials, growing awareness

Details

Duchenne Muscular Dystrophy Treatment Market Outlook, Trend, Growth and Share Estimation Analysis

Duchenne Muscular Dystrophy Treatment Market: Introduction Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive degeneration of the muscles and weakness in them. It is a rare muscle disease, which largely affects men. Read Report Overview - https://www.transparencymarketresearch.com/duchenne-muscular-dystrophy-treatment-market.html Duchenne muscular dystrophy (DMD) therapeutics help treat this genetic disorder caused due to absence of dystrophin, a protein in the human body. Symptoms of the disease include weakness in the muscles of the hips, the thighs, the pelvic area, and the shoulders. Later, weakness is observed in the muscles of the arms, the legs, and the trunk. Various therapies and drugs to control DMD are available, which include mutation suppression, exon skipping, and steroid therapy. DMD is caused by changes (mutations) of the DMD gene on the X chromosome Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75539 Key Drivers and Restraints of Global Duchenne Muscular Dystrophy

Details

Erythropoiesis-stimulating Agents Market Incredible Potential Examined in New Research Report

The process of formation of red blood cells is termed as erythropoiesis. Erythropoiesis takes place in the bone marrow. Agents promoting synthesis of red blood cells are known as erythropoiesis-stimulating agents. These are recombinant versions of a hormone erythropoietin, which is naturally produced by the kidneys and is responsible for stimulating bone marrow for red blood cells synthesis. Erythropoiesis-stimulating agents are recommended for the treatment of anemia.  Hemoglobin is a substance in red blood cells, which carries oxygen around the body. Read Report Overview - https://www.transparencymarketresearch.com/erythropoiesis-stimulating-agents-market.html When the body does not receive enough oxygen because of less number of red blood cells, it results into anemia. Anemia is highly associated with chronic kidney disease, and the overall prevalence rate of the disease in the U.S. is 15%. About 50% of the population with advanced diseases develop anemia. Hence, besides the use of dialysis, the development and use of erythropoiesis-stimulating agents are significant advancements

Details

Chagas Disease Treatment Market to Explore Emerging Trends of Coming Years

Global Chagas Disease Treatment Market: Overview Chagas disease is a health condition caused by protozoan parasite named Trypanosoma cruzi. This disease is also known as American trypanosomiasis. The insects are also called as Triatominae or "kissing bugs," which are responsible for the spread of the disease in humans as well as in animals. In the U.S., chagas disease is considered as one of the NPI (Neglected Parasitic Infection). The Centers for Disease Control and Prevention for community health action has targeted this disease. Increased number of people living with this disease is driving the growth of the global chagas disease treatment market. The bifurcation of the global chagas disease treatment market is performed based on three important parameters, namely, treatment, end-user, and region. In terms of treatment, the market is sub-segmented into two parts, namely, medication and other possible treatments. Based on application, the chagas disease treatment market segmentation is done into clinical laboratories and hospital. The report provides adept assessment of the global

Details

Renal Biomarkers Market is Set to Grow According to Latest Research

Biomarker is a measurable biological indicator of the health status of an individual, especially of one at the risk of developing or presence of a particular disease. In the past, the term ‘biomarker’ referred to physiological traits, however, with the advent of technologically advanced diagnostic measures, biomarkers now refer to products of metobolomic, genomic, and proteomic research. Read Report Overview - https://www.transparencymarketresearch.com/renal-biomarkers-market.html Chronic kidney disease (CKD) is a major risk multiplier for cardiovascular disease, diabetes, hypertension, inflammatory disease of kidney (glomerulonephritis), and aging. World Kidney Day, a global awareness campaign, estimated that 10% of the global population is affected by chronic kidney disease. According to the Centers for Disease Control and Prevention (CDC), more than 26 million Americans are affected by chronic kidney disease. Chronic kidney disease leads to end-stage renal disease (ESRD), if not treated. It was estimated by the National Kidney Foundation in 2015 that about 468,000 ESRD

Details

Global Laser Fibers & Accessories Market Analysis & Key Business Strategies by Leading Industry Players

Fibers laser are lasers that made of optical fibers and act as a gain medium (a medium which can amplify the power of light) for different purposes like cutting, penetrating etc. Fibers laser have high output power, reliability properties. The fiber laser gives high proficiency, cost adequacy, minimal size, vibrational steadiness, and low support, which makes them perfect for use in enhanced applications. The modern optical fiber lasers is more minimal, effective, and solid when compare with traditional lasers. Read Report Overview - https://www.transparencymarketresearch.com/laser-fibers-accessories-market.html Initially, fibers laser were used to cut, vaporize, and removed soft tissue but their usages in the medical field has remarkably increased recently. In view of their minimized size, various wavelength and single-mode operation, fibers laser are now utilized for a variety of medicinal applications that depend on particular wavelength and are of uses. Maintenance free operation makes fibers laser exceptionally appealing for specialists and in the medical field. Based on equipment

Details

Global Proteins C & S Market Incredible Potential, Stagnant Progress According to New Research Report

Protein C is a vitamin K-dependent glycoprotein produced in the liver and circulated in blood as an inactive enzyme precursor. In order to get itself activated, protein C binds to endothelial proteoglycan thrombomodulin, generally catalyzed by thrombin. The anticoagulant activity by activated protein C is exerted primarily through inactivation of coagulation factors viz. VIIIa and Va, which are required for activation of factor X and production of thrombin. Read Report Overview - https://www.transparencymarketresearch.com/proteins-c-s-market.html The catalytic activity of the activated protein C requires assistance of protein S, a vitamin K-dependent co-factor. Protein S assists protein C in the inactivation of coagulation factors viz. Va and VIIIa. The half-life of protein C is eight hours and that of protein S is 30 hours. Lack of activated protein C interrupts and disturbs the equilibrium between procoagulant and anticoagulant proteins and stimulates a prothrombotic environment. Apart from maintaining balance or equilibrium, activated protein C helps in maintaining an appropriate

Details

Biologics Outsourcing Market Overview and Regional Outlook Study

Biologics Outsourcing Market: Introduction Biologics can be defined as drugs derived from living organisms, or those which contain components of living organisms. These include a range of products, including those derived from human, animals, or microorganisms by employing biotechnology. Read Report Overview - https://www.transparencymarketresearch.com/biologics-outsourcing-market.html Biologic drugs are available for the treatment of a range of diseases, including various forms of cancer, autoimmune diseases, chronic diseases, cardiovascular diseases, and ophthalmic diseases Biologics enhance the specificity of treatment for specific disease conditions, as biologic entities such as monoclonal antibodies and recombinant proteins target specific molecular mechanisms of the disease action Biologics are highly preferred owing to their efficacy and specificity. Additionally, increase in regulatory approvals drives demand for biologics at various levels of clinical studies and commercial supplies. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75421 Key

Details

Early Toxicity Testing Market Research Described in a New Market Report

Early Toxicity Testing Market: Introduction An early toxicity testing or screening is the process of safety assessment which determines the level of tissue or cell damage and maximum safe concentration of any chemical or drug. It is generally performed during preclinical development of products. Toxicology testing may also be carried out to determine the approximate amount and type of drugs present in the blood such as alcohol, amphetamine, barbiturates, benzodiazepine, and cocaine. Read Report Overview - https://www.transparencymarketresearch.com/early-toxicity-testing.html Key methods used for toxicology testing are in vivo testing, in vitro testing, and in silico testing In vivo testing utilizes test animals to carry out desired testing process. It can be categorized into two types: acute in vivo testing (short-term testing) and chronic in vivo testing (long-term testing). In vitro experimentation uses isolated cells from different organisms, including humans, depending on the type of cell needed to perform the specific research activity In silico method, also known as

Details

Partial Onset Seizures Market Demand and Competitive Analysis by Leading Manufacturers

Partial Onset Seizures Market: Introduction Partial onset seizure occurs due to abnormal electrical activity in one part of the brain. It is also known as focal seizure. Focal seizures can be of two types: focal seizure without loss of consciousness and focal seizure with impaired awareness. Focal seizure without loss of consciousness is known as simple partial seizure, while focal seizure with impaired awareness is known as complex partial seizure. Read Report Overview - https://www.transparencymarketresearch.com/partial-onset-seizures-market.html A seizure is a transient disruption of brain function due to abnormal and excessive electrical discharges in brain cells. According to the American Epilepsy Society, around 14% of individuals suffers from simple partial seizure, while 36% individuals with epilepsy have complex partial seizure. Key Drivers of Global Partial Onset Seizures Market The global partial onset seizures market is projected to be driven by rise in prevalence of epilepsy. Incidence of epilepsy is higher in developing countries due to late diagnosis and

Details

Synthetic Lethality-based Drugs and Targets Market: Comprehensive study explores Huge Growth in Future

Synthetic Lethality-based Drugs and Targets Market: Introduction Synthetic lethality occurs when a combination of two deficiencies arises and results into organismal or cellular death. It was first described by American geneticist Calvin Bridges in the 20th century. Efficacy in tumor therapy increases by targeting synthetic lethal interaction with drug combination. Synthetic lethality is an important therapeutic option for the treatment of cancer. Read Report Overview - https://www.transparencymarketresearch.com/synthetic-lethality-based-drugs-and-targets-market.html Key Drivers and Opportunities for Global Synthetic Lethality-based Drugs and Targets Market Companies operating in the global synthetic lethality-based drugs and targets market are engaged in development of new products. These players constantly focus on research and development activities. This is driving the global synthetic lethality-based drugs and targets market. GlaxoSmithKline plc. registered a new drug GSK3985771 † niraparib Zejula for ovarian cancer monotherapy. The mode of action includes poly

Details

Anti-infective Drugs Market: Study Navigating the Future Growth Outlook

The anti-infective viral drugs to witness robust growth as infectious diseases continue to rise amidst changing weather patterns globally. The prevalence of diseases like malaria, chikungunya, and chagas disease are also expected to drive demand for anti-infective viral drugs market in the near future. According to WHO or the World Health Organization, Vector borne illnesses account for over 700,000 deaths annually. Moreover, these disease account for 17% of all the common infectious diseases. This affects over 3.9 billion people in over 128 countries with spread of illnesses like dengue and nearly a 100 million cases are estimated each year. Moreover, diseases like malaria have also seen massive global prevention efforts each year. Foundation like the Melinda and Bill Gates foundation has invested large sums of money in preventing diseases like Malaria. This disease causes more than 400,000 deaths each year and the global efforts are expected to drive significant demand for anti-infective viral drugs to counter the threat of the disease. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41204 Moreover

Details

Non-opioid Pain Patch Market Scrutinized in the New Analysis

A new research report on the global non-opioid pain patch market expects that the market will achieve a stellar growth in the next few years of the mentioned forecast period of 2016 to 2024. The growth of the market is expected to grow at a great pace because of the increasing opioid misuse that has fueled the demand for a safer and non-addictive analgesic drug to treat pain. The global non-opioid pain patch market has a highly consolidated vendor landscape with only a handful of notable names in operation. Some of the notable names in the global non-opioid pain patch market include names such as Mylan NV, Endo International Plc., Hisamitsu Pharmaceutical Co. Inc., Teikoku Seiyaku Co. Ltd., IBSA Institut Biochimque SA, TEH SENG Pharmaceutical Mfg. Co. Ltd., Pfizer Inc., GlaxoSmithKline Plc., Acorda Therapeutics Inc., and ALLERGEN among others. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26168 Product Development is Key Focus for Market Leaders The leading players in the global market for non-opioid pain patch share a

Details

Prenatal Vitamins Supplements Market Discussed in a New Market Research Report

The demand within the global market for prenatal vitamin supplements has been rising on account of the focus given on the health of pregnant women, finds Transparency Market Research (TMR). The presence of a stellar industry for women healthcare has also aided the growth of the global prenatal vitamin supplements market. It is expected that the market vendors in the global prenatal vitamin supplements market would capitalise on innovative marketing hacks in order to drive consumer traffic. The market vendors have also found multiple avenues for selling their products which has in turn improved the competitive landscape. The key vendors within the global prenatal vitamin supplements market have been focusing on building a robust consumer-base that aids market growth. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18668 The market for prenatal vitamin supplements is expected to become increasingly fragmented over the years to follow. This owes to the entry of a massive number of newbie vendors into the global prenatal vitamin

Details

Animal Blood Plasma Products and Derivatives Market Research Available in the Latest Report

The global animal blood plasma products and derivatives market is has a fragmented vendor landscape due to the presence of several players, Transparency Market Research (TMR) observes. Strategic partnership, acquisitions, and mergers are key startegies that these companies have adopted to gain a stronger foothold in the market. This trend have strengthen their presence and helped for business expansion globally. Some of the key players operating in the global animal blood plasma products and derivatives market include Lake Immunogenics Inc., Kraeber & Co. GmbH, Auckland BioSciences Ltd., Sigma-Aldrich Co., Rocky Mountain Biologicals Inc., Thermo Fisher Scientific Inc., Bovogen Biologicals Pty Ltd., Proliant Inc., LAMPIRE Biological Laboratories Inc., and ANZCO Foods Ltd. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21455 The global animal plasma products and derivative market was valued at US$1.04 bn in 2015 and is estimated to attain the value of US$1.92 bn by the end of 2024 at a CAGR of 7.10% over the forecast period

Details
Page 1 of 135
FREE BLOG/SBM SITES
Categories